Capstan Therapeutics
Capstan Therapeutics is a biotech founded in 2021 that was acquired by AbbVie and is headquartered in the United States.
Facts
- HQ
- United States
- Sectors
- Biotechnology, Life Sciences, Research & Development
- Founded
- 2021
- Stage
- Acquired
Shield AI Leads San Diego VC in 2025 with $240M Series F at $5B Valuation; Crystalys Raises $205M Series A
San Diego startups raised more than $100 million across 11 local companies in 2025, led by Shield AI’s $240M Series F at a $5B valuation and Crystalys Therapeutics’ $205M Series A; overall deal count fell 6% year-over-year to 152. Three San Diego companies — Aardvark Therapeutics, Carlsmed and Aptera Motors — went public, and the city ranked seventh nationally for VC funding through Series C.
